Publication Resources

• Geographic variation in long-term health outcomes following myocardial infarction in England. C Sturley, T del Toro, JA Batty, E Booth, M Hall. Heart [in press May 2026]. Doi: 10.1136/heartjnl-2025-327671


• Cluster separation outperforms other metrics in validating multimorbidity patterns: statistical simulation study. T. Ba Dhafari, A. Pate, Glen Martin, James Rafferty, F. Jalali-najafabadi, M. Hall, N. Peek. Journal of Clinical Epidemiology 2026;194(112209) https://doi.org/10.1016/j.jclinepi.2026.112209 [In press, 2026 [accepted 2/3/2026]).


• Long-term accrual of conditions following myocardial infarction: a study of disease trajectories in the Wales Multimorbidity e-Cohort. J. A. Batty, C.J. Hayward, R.A. Lyons, C.P. Gale, N. Peek, and M. Hall. 2025 BMC Medicine 23, 710 (2025). https://doi.org/10.1186/s12916-025-04520-1


• Multimorbidity in acute coronary syndrome: a systematic review and meta-analysis. JA. Batty, T del Toro, DJ Drayton, E Booth, E Anik, C Sturley, BC Brown, MT Kearney, M Hall. JACC: Advances, 4(8), p.102006. (2025). https://doi.org/10.1016/j.jacadv.2025.102006


• Health outcomes after myocardial infarction: a population study of 56 million people in England. M Hall, L Smith; J Wu et al. PLOS Medicine. 2024 Feb 15;21(2):e1004343. https://doi.org/10.1371/journal.pmed.1004343


• Determinants of multimorbidity in older adults in Iran: a cross-sectional study using latent class analysis on the Bushehr Elderly Health (BEH) program. Marzban M, [Hall M], et al. BMC Geriatr. 2024 Mar 11;24(1):247. doi: 10.1186/s12877-024-04848-y.


• Disease trajectories following myocardial infarction: insights from process mining of 145 million hospitalisation episodes. CJ. Hayward, JA. Batty, DR. Westhead, O Johnson, CP. Gale, J Wu, M Hall. eBioMedicine (96):2023


• J Lyons; A Akbari; KR Abrams; [M Hall] et al. Trajectories in chronic disease accrual and mortality across the lifespan in Wales, UK (2005-2019), by area deprivation profile: linked electronic health records cohort study on 965,905 individuals. Lancet Reg Health Eur 2023. 17;32:100687. doi: 10.1016/j.lanepe.2023.100687.


• Risk scores in Anaesthesia: the future is hard to predict. BJA Open, 2022. D.J. Drayton, M Ayres, S.D. Relton, M Sperrin, M Hall. 2022. https://doi.org/10.1016/j.bjao.2022.100027


• Protocol for the development of the Wales Multimorbidity e-Cohort (WMC): data sources and methods to construct a population-based research platform to investigate multimorbidity. Lyons J, Akbari A, Agrawal U, Harper G, Azcoaga-Lorenzo A, [Hall, M] et al., BMJ Open, 2021. 11:e047101. doi: 10.1136/bmjopen-2020-047101


• Association of multimorbidity and changes in health-related quality of life following myocardial infarction: a UK multicentre longitudinal patient-reported outcomes study. Munyombwe T, Dondo TB, Aktaa S, Wilkinson C, Hall M, et al., BMC Medicine, 2021;18:231.


• Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study. Wilkinson C, Clegg A, Todd O, Rockwood K, Yadegarfar ME, Gale CP, Hall M. Age and ageing 2021; 50(3):772-779.


• Association of treatments for acute myocardial infarction and survival for seven common comorbidity states: a nationwide cohort study. ME Yadegarfar, CP Gale, TB Dondo, CG Wilkinson, M R Cowie. M Hall. BMC Medicine 2020;18:231.


• Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction. B Hurdus, T Munyombwe, TB Dondo, S Aktaa, G Oliver, M Hall, P Doherty, AS Hall, CP Gale. Heart 2020. doi: 10.1136/heartjnl-2020-316920


• Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: Nationwide time series ecological analysis. J Wu, Alsaeed ES, J Barrett, M Hall, C Cowan, CP Gale. EUROPACE, 2020. 2020;22(9)p1311-1319.


• A nationwide causal mediation analysis of survival following ST-elevation Myocardial Infarction. Heart. TB Dondo, M Hall, T Munyombwe, C Wilkinson, M Yadegarfar, AD Timmis, PD Batin, T Jernberg, KAA Fox, CP Gale. Heart 2020;106:765-771.


• Quality of life trajectories in survivors of acute myocardial infarction: A national longitudinal study. T. Munyombwe, M Hall, TB Dondo, OA Alabas, G Oliver, RM West, M Pujades-Rodriguez, A Hall, CP Gale. Heart 2020;106:33-39.


• Is the association between blood pressure and mortality in older adults different with frailty? A systematic review and meta-analysis. Todd O, Wilkinson C, Hale M, [Hall M] et al. Age and Ageing 48(5):627-635 Sep 2019.


• International comparison of acute myocardial infarction care and outcomes using quality indicators. O Zusman, O Bebb, M Hall, TB Dondo, et al. Heart 2018. 105:820-825


• Multimorbidity and survival for patients with acute myocardial infarction, 2003-2013: Latent class analysis of a nationwide population-based cohort. M Hall, TB Dondo, AT Yan, MA Mamas, AD Timmis, JE Deanfield, T Jernberg, H Hemingway, KAA Fox, CP Gale. PloS Medicine 15(3) 2018.


• Association between time of hospitalization with acute myocardial infarction and in-hospital mortality. J Wu, M Hall, TB Dondo, C Wilkinson, P Ludman et al. European Heart Journal, 2018.


• Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. C Wilkinson, O. Todd, A Clegg, CP Gale and M Hall. Age and ageing 2019;48(2):196-203. doi: 10.1093/ageing/afy180


• Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study. C Wilkinson, O Bebb, TB Dondo, T Munyombwe, B Casadei, S Clarke, F Schiele, A Timmis, M Hall* (joint senior author), CP Gale. Heart 2019;105:516-523.


• Guideline-indicated treatments and diagnostics, GRACE risk score and survival for non-ST elevation myocardial infarction. M Hall, O Bebb, TB Dondo et al. European Heart Journal 2018 39(42)3798-3806.


• Frailty and acute coronary syndrome: a structured literature review. O. Bebb, FGD Smith, A. Clegg, M. Hall, C.P. Gale. European Heart Journal: Acute Cardiovascular Care Volume 7 Issue 2, (2018) doi.org/10.1177/2048872617700873.


• Beta-Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. TB Dondo, M Hall (contribution: specialist methodologist), RM West et al. Journal of the American College of Cardiology (2017) 69(22):2710-2720. [National Press Coverage, 30 May 2017]


• Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register. O. Bebb, M. Hall (contribution: specialist methodologist), KAA Fox et al. Eur Heart J (2017) 38 (13): 974-982.


• Association of clinical factors and therapeutic strategies with improvements in survival following non ST-elevation myocardial infarction, 2003-2013. M. Hall, TB Dondo, A. Yan et al. Journal of the American Medical Association (2016) 316(10):1073-1082. [National Press Coverage, 30 Aug 2016]


• Impact of initial hospital diagnosis on mortality for acute myocardial infarction: a national cohort study. Eur Heart J Acute Cardiovascular Care. J. Wu, C.P. Gale, M. Hall, et al. 2016. Accepted July 2016. [National Press Coverage, 30 Aug 16]


• Long term excess mortality associated with diabetes following acute myocardial infarction: A population-based cohort study. OA Alabas, M Hall, TB Dondo et al. JECH, 2016. jech-2016-207402.


• Geographic variation in the treatment of non ST-segment myocardial infarction in the English National Health Service: a cohort study.TB Dondo, M Hall, CP Gale et al. BMJ Open. 2016;6:7 e011600


• Excess mortality and guideline-indicated care following non ST-elevation myocardial infarction. Dondo TB, Hall M., Timmis AD., et al. EHJ Acute Cardiovascular Care. 2016 advanced online publication. [National Press Coverage 10th May 2016]


• Patient and hospital determinants of primary percutaneous coronary intervention in England, 2003-13. Hall M, Laut K, Dondo TB, et al. Heart. 2016; doi:10.1136/heartjnl-2015-308616 [National Press Coverage 5th January 2016]


• Use of relative survival to evaluate non ST-elevation myocardial infarction quality of care and clinical outcomes. Hall M, Alabas OA, Dondo TB, Jernberg T, Gale CP. European Heart Journal Qual Care Clin Outcomes. 2015, 1.


• Accumulation and attenuation of cardiovascular benefit with glucagon-like peptide 1 receptor agonists. Batty, JA, T del Toro, M Hall. BMJ Med. 2026;5:e002704. https://doi.org/10.1136/bmjmed-2026-002704


• The impact of multiple long-term conditions on hospitilisation and mortality during winter: an example of the importance of linked, population-scale healthcare data. Batty JA, Smith L, Hall M. BMJ Med. 2024 Nov 12;3(1):e001114. doi: 10.1136/bmjmed-2024-001114. PMID: 39574423; PMCID: PMC11580320.


• Trends in ACEi and ARB expenditure: Compelling case for competition in generic drug markets. JA Batty, M Hall. International Journal of Cardiology (370), 2023.


• Risk scores in anaesthesia: the future is hard to predict. Drayton DJ, Ayres M, Relton SD, Sperrin M, Hall M. BJA Open. 2022 Sep 1;3:100027.


• Many heart attack patients prescribed beta-blockers may not benefit. M Hall. The Conversation. Republished verbatim by the British Heart Foundation, The Independent, EconoTimes, News Republic, Inkl.


• Investigating the national uptake of emergency operations for heart attack. M Hall. Case Study, Understanding Patient Data (Joint venture by Wellcome Trust, MRC, DoH, ESRC, PHE).

GitHub Resources